Paul will be attending CPHI in November and really looking forward to catching up with pharma partners old and new. He will also be on the lookout for CDMOs to help with development and manufacturing projects across nanoparticles, live biotherapeutics, cell therapies and custom polymer synthesis. It’s going to be a busy couple of days! Drop us a line if you’re going to be in Frankfurt too: [email protected].
3D Pharma Consulting will be attending CPHI 2022
5 October 2022
Client Feedback...
Paul has brought a wealth of knowledge across pharmaceutical formulation development, analytical chemistry and manufacturing science. He has a positive, problem solving and professional manner that, combined with his industry knowledge, has provided Innoture with valuable support during internal and client facing drug development activities. His collaborative and friendly approach considers how Innoture is organised and our aims for the company, whilst also being keen to get his hands dirty with the technical team or preparing well-presented documents. In addition to his CMC expertise, he has provided efficient and effective guidance of Innoture’s intellectual property activities, including IP identification, patent filings, IP strategy coordination with patent attorneys and FTO.
Ken Jones
CEO
Innoture Ltd